Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception

被引：52
|
作者：
Stanczyk F.Z. [1 ]
机构：
[1] Department of Obstetrics, University of Southern California, Keck School of Medicine, Los Angeles
来源：
Reviews in Endocrine and Metabolic Disorders | 2002年 / 3卷 / 3期
关键词：
Classification; Pharmacokinetics; Potency; Progestrins; Structure-function relationships;
D O I：
10.1023/A:1020072325818
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：211 / 224
页数：13
相关论文
共 50 条
  • [31] An Integrated Dialysis Pharmacometric (IDP) Model to Evaluate the Pharmacokinetics in Patients Undergoing Renal Replacement Therapy
    Broeker, Astrid
    Vossen, Matthias G.
    Thalhammer, Florian
    Wallis, Steven C.
    Lipman, Jeffrey
    Roberts, Jason A.
    Wicha, Sebastian G.
    PHARMACEUTICAL RESEARCH, 2020, 37 (06)
  • [32] n Ceftolozane/Tazobactam Pharmacokinetics in a Critically Ill Adult Receiving Continuous Renal Replacement Therapy
    Bremmer, Derek N.
    Nicolau, David P.
    Burcham, Pam
    Chunduri, Anil
    Shidham, Ganesh
    Bauer, Karri A.
    PHARMACOTHERAPY, 2016, 36 (05): : E30 - E33
  • [33] Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy
    Economou, Caleb J. P.
    Kielstein, Jan T.
    Czock, David
    Xie, Jiao
    Field, Jonathan
    Richards, Brent
    Tallott, Mandy
    Visser, Adam
    Koenig, Christina
    Hafer, Carsten
    Schmidt, Julius J.
    Lipman, Jeffrey
    Roberts, Jason A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (02) : 151 - 157
  • [34] Pharmacokinetics of ciprofloxacin during continuous renal replacement therapy in intensive care patients - new assessment
    Onichimowski, Dariusz
    Wolska, Joanna
    Ziolkowski, Hubert
    Nosek, Krzysztof
    Jaroszewski, Jerzy
    Czuczwar, Miroslaw
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2020, 52 (04) : 267 - 273
  • [35] An Integrated Dialysis Pharmacometric (IDP) Model to Evaluate the Pharmacokinetics in Patients Undergoing Renal Replacement Therapy
    Astrid Broeker
    Matthias G. Vossen
    Florian Thalhammer
    Steven C. Wallis
    Jeffrey Lipman
    Jason A. Roberts
    Sebastian G. Wicha
    Pharmaceutical Research, 2020, 37
  • [36] Pharmacokinetics of meropenem in children receiving continuous renal replacement therapy: Validation of clinical trial simulations
    Nehus, Edward J.
    Mizuno, Tomoyuki
    Cox, Shareen
    Goldstein, Stuart L.
    Vinks, Alexander A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (03): : 291 - 297
  • [37] Meropenem and continuous renal replacement therapy:: In vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients
    Isla, A
    Maynar, J
    Sánchez-Izquierdo, JA
    Gascón, AR
    Arzuaga, A
    Corral, E
    Pedraz, JL
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (11): : 1294 - 1304
  • [38] Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
    Langgartner, Julia
    Vasold, Antje
    Glueck, Thomas
    Reng, Michel
    Kees, Frieder
    INTENSIVE CARE MEDICINE, 2008, 34 (06) : 1091 - 1096
  • [39] Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
    Julia Langgartner
    Antje Vasold
    Thomas Glück
    Michel Reng
    Frieder Kees
    Intensive Care Medicine, 2008, 34 : 1091 - 1096
  • [40] Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment
    Baud, Frederic J.
    Houze, Pascal
    Carli, Pierre
    Lamhaut, Lionel
    THERAPIE, 2021, 76 (05): : 415 - 424
12345